Expanded label for Allergan eye implant

FDA approved an sNDA from Allergan Inc. (NYSE:AGN) for Ozurdex dexamethasone intravitreal implant to treat non-infectious uveitis affecting the posterior segment of the eye. The biodegradable implant ...